Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Università del Piemonte Orientale Home
Italiano
English
Cerca contenuto all’indirizzo Università del Piemonte Orientale
Home
Profili
Unità di ricerca
Apparecchiatura
Progetti
Risultato della ricerca
INTEGRATED PROFILING OF DIFFUSE LARGE B CELL LYMPHOMA WITH 7q GAIN
E CHIGRINOVA
, M MIAN
, Y SHEN
, GREINER TC
, CHAN WC
, VOSE JM
, G INGHIRAMI
, A CHIAPPELLA
, L BALDINI
, M PONZONI
, FERRERI AJM
, S FRANCESCHETTI
,
Gianluca GAIDANO
, A TUCCI
, F FACCHETTI
, T LAZURE
, O LAMBOTTE
, MORENO S MONTES
, PIRIS MA
, E ZUCCA
I KWEE, F. BERTONI
Mostra 2 più
Mostra meno
Dipartimento di Medicina Traslazionale
Risultato della ricerca
:
Contributo su rivista
›
Articolo in rivista
›
peer review
Panoramica
Fingerprint
Fingerprint
Entra nei temi di ricerca di 'INTEGRATED PROFILING OF DIFFUSE LARGE B CELL LYMPHOMA WITH 7q GAIN'. Insieme formano una fingerprint unica.
Ordina per
Peso
Alfabetico
Keyphrases
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Integrated Profiling
100%
MRNA Profiling
66%
Quantitative PCR
33%
Overall Survival
33%
Clinical Data
33%
MiRNA Target
33%
Chromosome 7
33%
Genomic Profiling
33%
Extranodal
33%
Mortality Rate
33%
Complete Response Rate
33%
Female Gender
33%
Differentially Expressed Transcripts
33%
Bone Marrow Involvement
33%
R-CHOP
33%
MiR-182
33%
Pregenomic RNA (pgRNA)
33%
Biochemistry, Genetics and Molecular Biology
B Cell
100%
LARGE
100%
Overall Survival
33%
RNA
33%
Real-Time Polymerase Chain Reaction
33%
MicroRNA
33%
Mortality Rate
33%
Chromosome 7
33%
Genomics
33%
Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
100%
microRNA
66%
Overall Survival
33%
Real Time Polymerase Chain Reaction
33%
Mortality Rate
33%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
33%
Chromosome 7
33%
Genomic RNA
33%
Neuroscience
B Cell
100%
MicroRNA
66%
Real-Time Polymerase Chain Reaction
33%
CHOP
33%
Chromosome 7
33%
Genomic RNA
33%
Immunology and Microbiology
B Cell
100%
Overall Survival
33%
Chromosome 7
33%
Real Time Polymerase Chain Reaction
33%
Mortality Rate
33%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
33%
Ribonucleic Acid
33%